Daniel Lynch, Director at Carisma Therapeutics, holds 161.43K shares in Carisma Therapeutics (Ticker: CARM), holds ― shares in Surface Oncology (Ticker: SURF), holds ― shares in Translate Bio (Ticker: ~TBIO).
Daniel Lynch latest transaction was an Uninformative Buy of ―.
What was Daniel Lynch's most profitable transaction?
Daniel Lynch’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daniel Lynch's role in Carisma Therapeutics?
Daniel Lynch's role in Carisma Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.